{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:27:37Z","timestamp":1775737657071,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s11936-018-0650-y","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T07:28:10Z","timestamp":1529393290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pregnancy Among Survivors of Childhood Cancer: Cardiovascular Considerations"],"prefix":"10.1007","volume":"20","author":[{"given":"Michael C.","family":"Honigberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy A.","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"issue":"2","key":"650_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83\u2013103.","journal-title":"CA Cancer J Clin"},{"key":"650_CR2","first-page":"xviii","volume-title":"The M.D. Anderson manual of medical oncology","author":"H Kantarjian","year":"2006","unstructured":"Kantarjian H, Koller CA, Wolff RA, University of Texas M.D. Anderson Cancer Center. The M.D. Anderson manual of medical oncology. New York: McGraw-Hill, Medical Pub.; 2006. p. xviii. 1149 p. p"},{"issue":"1","key":"650_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrc3634","volume":"14","author":"LL Robison","year":"2014","unstructured":"Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer. 2014;14(1):61\u201370.","journal-title":"Nat Rev Cancer"},{"key":"650_CR4","doi-asserted-by":"crossref","unstructured":"\u2022 Mulrooney DA, Armstrong GT, Huang S, Ness KK, Ehrhardt MJ, Joshi VM, et al. Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy: a cross-sectional study. Ann Intern Med. 2016;164(2):93\u2013101. In this large, cross-sectional study of childhood cancer survivors, comprehensive cardiovascular screening revealed subclinical cardiomyopathy, valvular disease, coronary disease, and conduction disease in a significant number of patients (newly identified in many cases).","DOI":"10.7326\/M15-0424"},{"issue":"1","key":"650_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.yapd.2017.03.014","volume":"64","author":"AJ Galligan","year":"2017","unstructured":"Galligan AJ. Childhood cancer survivorship and long-term outcomes. Adv Pediatr. 2017;64(1):133\u201369.","journal-title":"Adv Pediatr"},{"issue":"22","key":"650_CR6","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1001\/jama.2013.6296","volume":"309","author":"MM Hudson","year":"2013","unstructured":"Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309(22):2371\u201381.","journal-title":"JAMA"},{"issue":"13","key":"650_CR7","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1200\/JCO.2001.19.13.3163","volume":"19","author":"AC Mertens","year":"2001","unstructured":"Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME, Ruccione K, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2001;19(13):3163\u201372.","journal-title":"J Clin Oncol"},{"key":"650_CR8","doi-asserted-by":"crossref","unstructured":"\u2022 Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572\u201382. In this analysis of the Childhood Cancer Survivor Study, survivors (mean age 26.6\u00a0years) were found to have markedly higher rates of chronic medical conditions than their siblings, and nearly 75% had a chronic medical condition by 30\u00a0years after cancer diagnosis.","DOI":"10.1056\/NEJMsa060185"},{"issue":"4","key":"650_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/hrt.2007.136093","volume":"94","author":"SE Lipshultz","year":"2008","unstructured":"Lipshultz SE, Alvarez JA, Scully RE. Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart. 2008;94(4):525\u201333.","journal-title":"Heart"},{"issue":"3","key":"650_CR10","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1067\/S0002-9378(03)00837-8","volume":"189","author":"J Bar","year":"2003","unstructured":"Bar J, Davidi O, Goshen Y, Hod M, Yaniv I, Hirsch R. Pregnancy outcome in women treated with doxorubicin for childhood cancer. Am J Obstet Gynecol. 2003;189(3):853\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"650_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3322\/caac.21341","volume":"66","author":"G Curigliano","year":"2016","unstructured":"Curigliano G, Cardinale D, Dent S, Criscitiello C, Aseyev O, Lenihan D, et al. Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. CA Cancer J Clin. 2016;66(4):309\u201325.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"650_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/pbc.22908","volume":"56","author":"P Temming","year":"2011","unstructured":"Temming P, Qureshi A, Hardt J, Leiper AD, Levitt G, Ancliff PJ, et al. Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: retrospective cohort study in a single centre in the United Kingdom. Pediatr Blood Cancer. 2011;56(4):625\u201330.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"650_CR13","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.1997.15.4.1544","volume":"15","author":"JP Krischer","year":"1997","unstructured":"Krischer JP, Epstein S, Cuthbertson DD, Goorin AM, Epstein ML, Lipshultz SE. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol. 1997;15(4):1544\u201352.","journal-title":"J Clin Oncol"},{"issue":"26","key":"650_CR14","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJM199506293322602","volume":"332","author":"SE Lipshultz","year":"1995","unstructured":"Lipshultz SE, Lipsitz SR, Mone SM, Goorin AM, Sallan SE, Sanders SP, et al. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med. 1995;332(26):1738\u201343.","journal-title":"N Engl J Med"},{"issue":"1","key":"650_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1040-8428(97)10007-5","volume":"27","author":"A Giantris","year":"1998","unstructured":"Giantris A, Abdurrahman L, Hinkle A, Asselin B, Lipshultz SE. Anthracycline-induced cardiotoxicity in children and young adults. Crit Rev Oncol Hematol. 1998;27(1):53\u201368.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"15","key":"650_CR16","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1056\/NEJMra1100265","volume":"375","author":"JJ Moslehi","year":"2016","unstructured":"Moslehi JJ. Cardiovascular toxic effects of targeted cancer therapies. N Engl J Med. 2016;375(15):1457\u201367.","journal-title":"N Engl J Med"},{"issue":"20","key":"650_CR17","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1016\/j.jacc.2017.09.1096","volume":"70","author":"HM Chang","year":"2017","unstructured":"Chang HM, Moudgil R, Scarabelli T, Okwuosa TM, Yeh ETH. Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1. J Am Coll Cardiol. 2017;70(20):2536\u201351.","journal-title":"J Am Coll Cardiol"},{"issue":"42","key":"650_CR18","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Y Adler","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, Badano L, Bar\u00f3n-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921\u201364.","journal-title":"Eur Heart J"},{"issue":"7","key":"650_CR19","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1200\/JCO.1993.11.7.1208","volume":"11","author":"SL Hancock","year":"1993","unstructured":"Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin\u2019s disease in children and adolescents. J Clin Oncol. 1993;11(7):1208\u201315.","journal-title":"J Clin Oncol"},{"issue":"5","key":"650_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1161\/01.CIR.50.5.1033","volume":"50","author":"RD Greenwood","year":"1974","unstructured":"Greenwood RD, Rosenthal A, Cassady R, Jaffe N, Nadas AS. Constrictive pericarditis in childhood due to mediastinal irradiation. Circulation. 1974;50(5):1033\u20139.","journal-title":"Circulation"},{"issue":"12","key":"650_CR21","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.recesp.2015.10.011","volume":"68","author":"Y Adler","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, Badano L, Baron-Esquivias G, Bogaert J, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases. Rev Esp Cardiol (Engl Ed). 2015;68(12):1126.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"10","key":"650_CR22","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/0002-9149(83)90209-6","volume":"51","author":"MM Applefeld","year":"1983","unstructured":"Applefeld MM, Wiernik PH. Cardiac disease after radiation therapy for Hodgkin\u2019s disease: analysis of 48 patients. Am J Cardiol. 1983;51(10):1679\u201381.","journal-title":"Am J Cardiol"},{"issue":"7","key":"650_CR23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cjca.2016.02.065","volume":"32","author":"PC Nathan","year":"2016","unstructured":"Nathan PC, Amir E, Abdel-Qadir H. Cardiac outcomes in survivors of pediatric and adult cancers. Can J Cardiol. 2016;32(7):871\u201380.","journal-title":"Can J Cardiol"},{"key":"650_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fonc.2015.00039","volume":"5","author":"NK Taunk","year":"2015","unstructured":"Taunk NK, Haffty BG, Kostis JB, Goyal S. Radiation-induced heart disease: pathologic abnormalities and putative mechanisms. Front Oncol. 2015;5:39.","journal-title":"Front Oncol"},{"issue":"15","key":"650_CR25","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1200\/JCO.2004.09.109","volume":"22","author":"MJ Adams","year":"2004","unstructured":"Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, et al. Cardiovascular status in long-term survivors of Hodgkin\u2019s disease treated with chest radiotherapy. J Clin Oncol. 2004;22(15):3139\u201348.","journal-title":"J Clin Oncol"},{"issue":"1","key":"650_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0167-8140(97)00125-4","volume":"46","author":"C Glanzmann","year":"1998","unstructured":"Glanzmann C, Kaufmann P, Jenni R, Hess OM, Huguenin P. Cardiac risk after mediastinal irradiation for Hodgkin\u2019s disease. Radiother Oncol. 1998;46(1):51\u201362.","journal-title":"Radiother Oncol"},{"issue":"4","key":"650_CR27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0735-1097(03)00759-9","volume":"42","author":"PA Heidenreich","year":"2003","unstructured":"Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol. 2003;42(4):743\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"650_CR28","doi-asserted-by":"crossref","unstructured":"Cutter DJ, Schaapveld M, Darby SC, Hauptmann M, van Nimwegen FA, Krol AD, et al. Risk of valvular heart disease after treatment for Hodgkin lymphoma. J Natl Cancer Inst. 2015;107(4):1\u20139.","DOI":"10.1093\/jnci\/djv008"},{"issue":"7","key":"650_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11936-017-0550-6","volume":"19","author":"MH Stewart","year":"2017","unstructured":"Stewart MH, Jahangir E, Polin NM. Valvular heart disease in cancer patients: Etiology, Diagnosis, and Management. Curr Treat Options Cardiovasc Med. 2017;19(7):53.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"5","key":"650_CR30","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","volume":"109","author":"BM Aleman","year":"2007","unstructured":"Aleman BM, van den Belt-Dusebout AW, De Bruin ML, van\u2019t Veer MB, Baaijens MH, de Boer JP, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood. 2007;109(5):1878\u201386.","journal-title":"Blood."},{"issue":"3","key":"650_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0002-9343(81)90574-X","volume":"70","author":"FC Brosius 3rd","year":"1981","unstructured":"Brosius FC 3rd, Waller BF, Roberts WC. Radiation heart disease. Analysis of 16 young (aged 15 to 33\u00a0years) necropsy patients who received over 3500 rads to the heart. Am J Med. 1981;70(3):519\u201330.","journal-title":"Am J Med"},{"issue":"4","key":"650_CR32","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.amjcard.2015.11.027","volume":"117","author":"JM Bijl","year":"2016","unstructured":"Bijl JM, Roos MM, van Leeuwen-Segarceanu EM, Vos JM, Bos WW, Biesma DH, et al. Assessment of valvular disorders in survivors of Hodgkin\u2019s lymphoma treated by mediastinal radiotherapy \u00b1 chemotherapy. Am J Cardiol. 2016;117(4):691\u20136.","journal-title":"Am J Cardiol."},{"key":"650_CR33","first-page":"317659","volume":"2011","author":"SW Yusuf","year":"2011","unstructured":"Yusuf SW, Sami S, Daher IN. Radiation-induced heart disease: a clinical update. Cardiol Res Pract. 2011;2011:317659.","journal-title":"Cardiol Res Pract"},{"issue":"9","key":"650_CR34","doi-asserted-by":"publisher","first-page":"504","DOI":"10.4330\/wjc.v8.i9.504","volume":"8","author":"JR Cuomo","year":"2016","unstructured":"Cuomo JR, Sharma GK, Conger PD, Weintraub NL. Novel concepts in radiation-induced cardiovascular disease. World J Cardiol. 2016;8(9):504\u201319.","journal-title":"World J Cardiol"},{"issue":"6","key":"650_CR35","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jtcvs.2017.07.033","volume":"154","author":"JI Ejiofor","year":"2017","unstructured":"Ejiofor JI, Ramirez-Del Val F, Nohria A, Norman A, McGurk S, Aranki SF, et al. The risk of reoperative cardiac surgery in radiation-induced valvular disease. J Thorac Cardiovasc Surg. 2017;154(6):1883\u201395.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"650_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11883-017-0658-x","volume":"19","author":"D Raghunathan","year":"2017","unstructured":"Raghunathan D, Khilji MI, Hassan SA, Yusuf SW. Radiation-induced cardiovascular disease. Curr Atheroscler Rep. 2017;19(5):22.","journal-title":"Curr Atheroscler Rep"},{"issue":"16","key":"650_CR37","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1001\/jama.1993.03510160067031","volume":"270","author":"SL Hancock","year":"1993","unstructured":"Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin\u2019s disease. JAMA. 1993;270(16):1949\u201355.","journal-title":"JAMA"},{"issue":"1","key":"650_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1200\/JCO.2006.07.0805","volume":"25","author":"PA Heidenreich","year":"2007","unstructured":"Heidenreich PA, Schnittger I, Strauss HW, Vagelos RH, Lee BK, Mariscal CS, et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin\u2019s disease. J Clin Oncol. 2007;25(1):43\u20139.","journal-title":"J Clin Oncol"},{"issue":"10","key":"650_CR39","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/CIRCULATIONAHA.116.024811","volume":"135","author":"MM Fidler","year":"2017","unstructured":"Fidler MM, Reulen RC, Henson K, Kelly J, Cutter D, Levitt GA, et al. Population-based long-term cardiac-specific mortality among 34,489 five-year survivors of childhood cancer in Great Britain. Circulation. 2017;135(10):951\u201363.","journal-title":"Circulation"},{"issue":"11","key":"650_CR40","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987\u201398.","journal-title":"N Engl J Med"},{"issue":"5","key":"650_CR41","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jtcvs.2008.07.005","volume":"136","author":"ML Brown","year":"2008","unstructured":"Brown ML, Schaff HV, Sundt TM. Conduit choice for coronary artery bypass grafting after mediastinal radiation. J Thorac Cardiovasc Surg. 2008;136(5):1167\u201371.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"650_CR42","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/hrt.69.6.496","volume":"69","author":"F Orzan","year":"1993","unstructured":"Orzan F, Brusca A, Conte MR, Presbitero P, Figliomeni MC. Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment. Br Heart J. 1993;69(6):496\u2013500.","journal-title":"Br Heart J"},{"issue":"3","key":"650_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11912-016-0502-4","volume":"18","author":"K Marmagkiolis","year":"2016","unstructured":"Marmagkiolis K, Finch W, Tsitlakidou D, Josephs T, Iliescu C, Best JF, et al. Radiation toxicity to the cardiovascular system. Curr Oncol Rep. 2016;18(3):15.","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"650_CR44","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jacc.2016.11.040","volume":"69","author":"KA Thompson","year":"2017","unstructured":"Thompson KA, Hildebrandt MA, Ater JL. Cardiac outcomes with pregnancy after cardiotoxic therapy for childhood cancer. J Am Coll Cardiol. 2017;69(5):594\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"650_CR45","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/j.ejca.2006.04.014","volume":"42","author":"EC Dalen van","year":"2006","unstructured":"van Dalen EC, van der Pal HJ, van den Bos C, Kok WE, Caron HN, Kremer LC. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines. Eur J Cancer. 2006;42(15):2549\u201353.","journal-title":"Eur J Cancer"},{"issue":"1","key":"650_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11764-015-0457-8","volume":"10","author":"MR Hines","year":"2016","unstructured":"Hines MR, Mulrooney DA, Hudson MM, Ness KK, Green DM, Howard SC, et al. Pregnancy-associated cardiomyopathy in survivors of childhood cancer. J Cancer Surviv. 2016;10(1):113\u201321.","journal-title":"J Cancer Surviv"},{"key":"650_CR47","unstructured":"\u2022\u2022 Group CsO. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers, version 4.0 Monrovia, CA: Children\u2019s Oncology Group; 2013 [Available from: www.survivorshipguidelines.org . This is the only available guideline on recommended frequency of echocardiographic screening for childhood cancer survivors who received anthracyclines and\/or chest radiation."},{"issue":"4","key":"650_CR48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jacc.2011.04.014","volume":"58","author":"K Stergiopoulos","year":"2011","unstructured":"Stergiopoulos K, Shiang E, Bench T. Pregnancy in patients with pre-existing cardiomyopathies. J Am Coll Cardiol. 2011;58(4):337\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"650_CR49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jacc.2016.05.048","volume":"68","author":"U Elkayam","year":"2016","unstructured":"Elkayam U, Goland S, Pieper PG, Silverside CK. High-Risk Cardiac Disease in Pregnancy: Part I. J Am Coll Cardiol. 2016;68(4):396\u2013410.","journal-title":"J Am Coll Cardiol"},{"key":"650_CR50","unstructured":"\u2022\u2022 European Society of G, Association for European Paediatric C, German Society for Gender M, Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147\u201397. This set of guidelines from the European Society of Cardiology provides recommendations for the management of cardiovascular disease before and during pregnancy."},{"issue":"2","key":"650_CR51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/00016349209007973","volume":"71","author":"YN Bakri","year":"1992","unstructured":"Bakri YN, Martan A, Amri A, Amri M. Pregnancy complicating irradiation-induced constrictive pericarditis. Acta Obstet Gynecol Scand. 1992;71(2):143\u20134.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"16","key":"650_CR52","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1161\/CIRCULATIONAHA.113.002054","volume":"129","author":"U Elkayam","year":"2014","unstructured":"Elkayam U, Jalnapurkar S, Barakkat MN, Khatri N, Kealey AJ, Mehra A, et al. Pregnancy-associated acute myocardial infarction: a review of contemporary experience in 150 cases between 2006 and 2011. Circulation. 2014;129(16):1695\u2013702.","journal-title":"Circulation"},{"issue":"5","key":"650_CR53","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/CIRCEP.114.001517","volume":"7","author":"AD Enriquez","year":"2014","unstructured":"Enriquez AD, Economy KE, Tedrow UB. Contemporary management of arrhythmias during pregnancy. Circ Arrhythm Electrophysiol. 2014;7(5):961\u20137.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"650_CR54","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccep.2015.03.010","volume":"7","author":"MC Honigberg","year":"2015","unstructured":"Honigberg MC, Givertz MM. Arrhythmias in peripartum cardiomyopathy. Card Electrophysiol Clin. 2015;7(2):309\u201317.","journal-title":"Card Electrophysiol Clin"},{"issue":"24","key":"650_CR55","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr272","volume":"32","author":"V Regitz-Zagrosek","year":"2011","unstructured":"Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147\u201397.","journal-title":"Eur Heart J"},{"key":"650_CR56","doi-asserted-by":"crossref","unstructured":"Elkayam U, Goland S, Pieper PG, Silverside CK. High-risk cardiac disease in pregnancy: part II. J Am Coll Cardiol. 2016.","DOI":"10.1016\/j.jacc.2016.05.050"},{"issue":"8","key":"650_CR57","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1161\/CIR.0000000000000458","volume":"135","author":"MM Canobbio","year":"2017","unstructured":"Canobbio MM, Warnes CA, Aboulhosn J, Connolly HM, Khanna A, Koos BJ, et al. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017;135(8):e50\u201387.","journal-title":"Circulation"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-018-0650-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-018-0650-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-018-0650-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T22:37:39Z","timestamp":1604443059000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-018-0650-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["650"],"URL":"https:\/\/doi.org\/10.1007\/s11936-018-0650-y","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"assertion":[{"value":"19 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Michael C. Honigberg and Amy A. Sarma each declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"54"}}